Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia

Lignende værker

• Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich's Ataxia: A New Synthetic Route
  af: Xu, Chunping, et al.
  Udgivet: (2011)
• Chemical probes identify a role for histone deacetylase 3 in Friedreich’s ataxia gene silencing
  af: Xu, Chunping, et al.
  Udgivet: (2009)
• Evaluation of Histone Deacetylase Inhibitors as Therapeutics for Neurodegenerative Diseases
  af: Soragni, Elisabetta, et al.
  Udgivet: (2011)
• Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
  af: Soragni, Elisabetta, et al.
  Udgivet: (2015)
• Increasing Frataxin Gene Expression with Histone Deacetylase Inhibitors as a Therapeutic Approach for Friedreich's Ataxia
  af: Gottesfeld, Joel M., et al.
  Udgivet: (2013)